Ushering in a New Class of Disease-Modifying DTx
A deep discussion on the science and engineering behind an emerging class of treatments that use novel neuro-physiology technologies to treat therapeutic targets that have proven undruggable for decades. A look at how these technologies can realize disease-modification for the first time in diseases like Alzheimer's, Cognitive decline, MS, and neuro-psychological conditions such as schizophrenia.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.
Nancy Isenberg
Swedish Neuroscience Institute

Eddie Martucci
Akili Interactive

Georgia Mitsi
Biogen

Brent Vaughan
Cognito Therapeutics
Primary Access
Interactive Badge
Platinum Badge
Secondary Access
Film Badge
Music Badge